Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Yeon Seok | - |
dc.contributor.author | Kim, Jin Nam | - |
dc.contributor.author | Keum, Bora | - |
dc.contributor.author | Park, Sanghoon | - |
dc.contributor.author | Kwon, Yong Dae | - |
dc.contributor.author | Kim, Yong Sik | - |
dc.contributor.author | Jeen, Yoon Tae | - |
dc.contributor.author | Chun, Hoon Jai | - |
dc.contributor.author | Kim, Chul Yong | - |
dc.contributor.author | Kim, Chang Duck | - |
dc.contributor.author | Ryu, Ho Sang | - |
dc.contributor.author | Um, Soon Ho | - |
dc.date.accessioned | 2022-01-08T10:41:46Z | - |
dc.date.available | 2022-01-08T10:41:46Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2008-04-21 | - |
dc.identifier.issn | 1007-9327 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/134875 | - |
dc.description.abstract | AIM: To evaluate the efficacy of radiotherapy (RT) in patients with advanced unresectable hepatocellular carcinoma (HCC). METHODS: A total of 65 patients were treated with RT in the Korea University Medical Center. The median age of the patients was 60 years, and 86.2% were men. 18.5% and 81.5% of the patients were diagnosed as TNM stage M and IV-A, respectively. Treatment response was assessed 4 mo after initiation of RT. Tumor regression rate I mo after initiation of RT (TRR1m) was also assessed. Duration of survival was calculated from the initiation of RT. RESULTS: The objective treatment response was 56.9%. The 12 mo survival rate was 34.7%. Predictive factors for survival were Child-Pugh grade, alpha-fetoprotein level and treatment response. An objective response was achieved more frequently in patients with TRR1m >= 20% than in those with TRR1m < 20% (P < 0.001). CONCLUSION: RT is effective in treating advanced HCC with a tumor response rate of 56.9%. (c) 2008 WJG. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BAISHIDENG PUBLISHING GROUP INC | - |
dc.subject | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | - |
dc.subject | PRIMARY LIVER-CANCER | - |
dc.subject | LOCAL RADIOTHERAPY | - |
dc.subject | REGIONAL CHEMOTHERAPY | - |
dc.subject | HEPATIC RESECTION | - |
dc.subject | MANAGEMENT | - |
dc.subject | RADIATION | - |
dc.subject | SURVIVAL | - |
dc.subject | FLUORODEOXYURIDINE | - |
dc.subject | EXPERIENCE | - |
dc.title | Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Yeon Seok | - |
dc.contributor.affiliatedAuthor | Keum, Bora | - |
dc.contributor.affiliatedAuthor | Kim, Yong Sik | - |
dc.contributor.affiliatedAuthor | Jeen, Yoon Tae | - |
dc.contributor.affiliatedAuthor | Chun, Hoon Jai | - |
dc.contributor.affiliatedAuthor | Kim, Chul Yong | - |
dc.contributor.affiliatedAuthor | Kim, Chang Duck | - |
dc.contributor.affiliatedAuthor | Ryu, Ho Sang | - |
dc.contributor.affiliatedAuthor | Um, Soon Ho | - |
dc.identifier.doi | 10.3748/wjg.14.2394 | - |
dc.identifier.scopusid | 2-s2.0-45849118668 | - |
dc.identifier.wosid | 000255252700016 | - |
dc.identifier.bibliographicCitation | WORLD JOURNAL OF GASTROENTEROLOGY, v.14, no.15, pp.2394 - 2400 | - |
dc.relation.isPartOf | WORLD JOURNAL OF GASTROENTEROLOGY | - |
dc.citation.title | WORLD JOURNAL OF GASTROENTEROLOGY | - |
dc.citation.volume | 14 | - |
dc.citation.number | 15 | - |
dc.citation.startPage | 2394 | - |
dc.citation.endPage | 2400 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | - |
dc.subject.keywordPlus | PRIMARY LIVER-CANCER | - |
dc.subject.keywordPlus | LOCAL RADIOTHERAPY | - |
dc.subject.keywordPlus | REGIONAL CHEMOTHERAPY | - |
dc.subject.keywordPlus | HEPATIC RESECTION | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | RADIATION | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | FLUORODEOXYURIDINE | - |
dc.subject.keywordPlus | EXPERIENCE | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | radiotherapy | - |
dc.subject.keywordAuthor | treatment response | - |
dc.subject.keywordAuthor | survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.